Tivic Health Systems (TIVC) CFO exercises restricted stock units into common shares

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Tivic Health Systems, Inc. Chief Financial Officer Lisa G. Wolf exercised restricted stock units that converted into 92 shares of Common Stock on March 18, 2026. The shares were acquired at a conversion price of $0.00 per share, reflecting compensation rather than an open-market purchase.

Following the transactions, Wolf directly holds 526 shares of Common Stock and 643 Restricted Stock Units. The filing notes these figures reflect a 1-for-17 reverse stock split completed on March 7, 2025, and that the RSUs vest over three years from December 18, 2023.

Insider Trade Summary

92 shares exercised/converted

Mixed 2 txns

Insider Wolf Lisa G

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	92	$0.00	--
Exercise	Common Stock	92	$0.00	--

Holdings After Transaction: Restricted Stock Units — 643 shares (Direct); Common Stock — 526 shares (Direct)

Footnotes (1)

Each Restricted Stock Unit is convertible into one share of Common Stock. These numbers have been adjusted to reflect the reverse stock split of the common stock of Tivic Health Systems, Inc., which underwent a reverse stock split at a ratio of 1-for-17 on March 7, 2025. Fifty percent (50%) of the Restricted Stock Units vested upon the one (1) year anniversary of the date of grant, December 18, 2024 (the "Vesting Commencement Date"), and the balance of the Restricted Stock Units will be vested in a series of eight (8) successive equal quarterly installments measured from the first anniversary of the Vesting Commencement Date such that one hundred percent (100%) of the Restricted Stock Units shall have vested on the third anniversary of the Vesting Commencement Date.

Form 4 Insider Transactions: What Each Field Means →

03/19/2026 - 09:14 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wolf Lisa G

(Last)

(First)

(Middle)

1305 E. HOUSTON ST., BLDG 1, STE. 311

(Street)

SAN ANTONIO

TEXAS

78205

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Tivic Health Systems, Inc. [ TIVC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/18/2026		M		92	A	⁽¹⁾	526⁽²⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽¹⁾	03/18/2026		M			92	⁽³⁾	⁽³⁾	Common Stock	92	$0	643⁽²⁾	D

Explanation of Responses:

1. Each Restricted Stock Unit is convertible into one share of Common Stock.

2. These numbers have been adjusted to reflect the reverse stock split of the common stock of Tivic Health Systems, Inc., which underwent a reverse stock split at a ratio of 1-for-17 on March 7, 2025.

3. Fifty percent (50%) of the Restricted Stock Units vested upon the one (1) year anniversary of the date of grant, December 18, 2024 (the "Vesting Commencement Date"), and the balance of the Restricted Stock Units will be vested in a series of eight (8) successive equal quarterly installments measured from the first anniversary of the Vesting Commencement Date such that one hundred percent (100%) of the Restricted Stock Units shall have vested on the third anniversary of the Vesting Commencement Date.

	/s/ Lisa Wolf	03/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Tivic Health Systems (TIVC) report for Lisa G. Wolf?

Tivic Health Systems reported that CFO Lisa G. Wolf exercised restricted stock units into 92 shares of Common Stock. This was a compensation-related derivative conversion, not an open-market share purchase or sale, and reflects the vesting of previously granted equity awards.

How many Tivic Health Systems (TIVC) shares does CFO Lisa G. Wolf hold after this Form 4?

After the reported transactions, CFO Lisa G. Wolf directly holds 526 shares of Tivic Health Systems Common Stock. She also has 643 Restricted Stock Units outstanding, which are scheduled to continue vesting over time according to the original grant’s vesting schedule.

What was the size of the restricted stock unit exercise reported by Tivic Health Systems (TIVC)?

The filing shows an exercise of restricted stock units covering 92 underlying shares of Common Stock. Each Restricted Stock Unit converts into one share, so 92 RSUs became 92 shares in a routine compensation-related transaction, with no open-market purchase price involved.

How are Tivic Health Systems (TIVC) RSUs for Lisa G. Wolf vesting over time?

Fifty percent of Lisa G. Wolf’s Restricted Stock Units vested on December 18, 2024, one year after the grant date. The remaining units vest in eight equal quarterly installments, so the entire RSU grant is scheduled to be fully vested by the third anniversary of that date.

How did Tivic Health Systems’ (TIVC) reverse stock split affect the Form 4 figures?

The share and RSU numbers in the Form 4 were adjusted for Tivic Health Systems’ 1-for-17 reverse stock split completed on March 7, 2025. This means all reported quantities, including Wolf’s holdings and exercises, are presented on a post-split, comparable basis.